US Patent 7776539 SENP1 as a marker for cancer
Patent 7776539 was granted and assigned to Roche Molecular Systems on August, 2010 by the United States Patent and Trademark Office.
All edits
Edits on 5 Jun, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 31 Oct, 2023
Golden AI
Edits made to:
Article (+145 characters)
Article
Patent abstract
The present invention provides methods of detecting cancer cells by detecting the quantity of SENP1 and/or telomerase in a sample.
Edits on 14 Jul, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 07776539 SENP1 as a marker for cancer US Patent 7776539 SENP1 as a marker for cancer
Infobox
Patent Number
0777653900
Patent Number
777653900
Edits on 23 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 3 Apr, 2023
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
077765390
Date of Patent
August 17, 2010
0Patent Application Number
121514820
Date Filed
May 6, 2008
0Official Website
Patent Primary Examiner
Edits on 27 Sep, 2022
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
077765390
Date of Patent
August 17, 2010
0Patent Application Number
121514820
Date Filed
May 6, 2008
0Official Website
Patent Primary Examiner
Edits on 3 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 5 Dec, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 07776539 SENP1 as a marker for cancer
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
07776539
Date of patent
August 17, 2010
Patent application number
12151482
Date Filed
May 6, 2008
Patent primary examiner
Find more entities like US Patent 7776539 SENP1 as a marker for cancer
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
